Geode Capital Management, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 551,798 shares of ARCT stock, worth $8.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

551,798

Previous 546,009 1.06%

Holding current value

$8.96 Million

Previous $13.3 Million 3.67%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$18.08 - $25.38 $104,665 - $146,924	5,789 Added 1.06%	551,798 $12.8 Million
Q2 2024 Aug 09, 2024	SELL	$24.35 - $44.39 $103,584 - $188,835	-4,254 Reduced 0.77%	546,009 $13.3 Million
Q1 2024 May 13, 2024	BUY	$31.23 - $42.99 $374,697 - $515,794	11,998 Added 2.23%	550,263 $18.6 Million
Q4 2023 Feb 13, 2024	BUY	$17.71 - $32.97 $462,177 - $860,418	26,097 Added 5.1%	538,265 $17 Million
Q3 2023 Nov 13, 2023	BUY	$25.44 - $37.35 $432,276 - $634,651	16,992 Added 3.43%	512,168 $13.1 Million
Q2 2023 Aug 11, 2023	BUY	$23.94 - $32.36 $647,816 - $875,661	27,060 Added 5.78%	495,176 $14.2 Million
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $267,565 - $435,702	18,177 Added 4.04%	468,116 $11.2 Million
Q4 2022 Feb 13, 2023	BUY	$14.14 - $23.06 $468,712 - $764,392	33,148 Added 7.95%	449,939 $7.63 Million
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $316,514 - $536,741	24,254 Added 6.18%	416,791 $6.18 Million
Q2 2022 Aug 12, 2022	BUY	$12.26 - $31.17 $264,252 - $671,838	21,554 Added 5.81%	392,537 $6.18 Million
Q1 2022 May 13, 2022	SELL	$17.64 - $39.57 $72,853 - $163,424	-4,130 Reduced 1.1%	370,983 $10 Million
Q4 2021 Feb 11, 2022	SELL	$34.2 - $47.56 $863,755 - $1.2 Million	-25,256 Reduced 6.31%	375,113 $13.9 Million
Q3 2021 Nov 12, 2021	BUY	$27.88 - $58.25 $467,045 - $975,804	16,752 Added 4.37%	400,369 $19.1 Million
Q2 2021 Aug 13, 2021	BUY	$25.79 - $42.11 $714,924 - $1.17 Million	27,721 Added 7.79%	383,617 $13 Million
Q1 2021 May 12, 2021	BUY	$38.75 - $86.92 $1.22 Million - $2.74 Million	31,500 Added 9.71%	355,896 $14.7 Million
Q4 2020 Feb 12, 2021	BUY	$34.61 - $123.66 $1.9 Million - $6.78 Million	54,862 Added 20.35%	324,396 $14.1 Million
Q3 2020 Nov 13, 2020	BUY	$37.49 - $63.19 $2.15 Million - $3.62 Million	57,333 Added 27.02%	269,534 $11.6 Million
Q2 2020 Aug 13, 2020	BUY	$12.66 - $58.27 $1.57 Million - $7.21 Million	123,714 Added 139.81%	212,201 $9.92 Million
Q1 2020 May 14, 2020	BUY	$9.31 - $18.26 $37,165 - $72,893	3,992 Added 4.72%	88,487 $1.2 Million
Q4 2019 Feb 13, 2020	BUY	$8.93 - $12.41 $51,302 - $71,295	5,745 Added 7.3%	84,495 $918,000
Q3 2019 Nov 12, 2019	BUY	$8.8 - $14.5 $574,437 - $946,516	65,277 Added 484.5%	78,750 $808,000
Q2 2019 Aug 14, 2019	BUY	$5.78 - $9.79 $77,873 - $131,900	13,473 New	13,473 $127,000

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $432M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Arcturus Therapeutics Holdings Inc. Transaction History